Tracking a promising leukemia treatment in everyday practice
NCT ID NCT07117136
Summary
This study aims to understand how well a drug called blinatumomab works for adults with B-cell acute lymphoblastic leukemia (B-ALL) when used in real-world hospital settings, not just in controlled clinical trials. Researchers will collect data from 200 patients across multiple centers who are receiving this drug as part of their standard treatment plan. The goal is to see if the promising results seen in earlier research hold up in everyday medical practice and to learn which treatment combinations work best.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Medical College of Wisconsin
RECRUITINGMilwaukee, Wisconsin, 53226, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.